SafeTide
PrivateLast Round
Accelerator
Aug 20, 2025
Company Overview
SafeTide is a biotechnology company developing low-cost stabilisation technology to keep delicate medicines like insulin stable at room temperature.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeTide Comparables
Compare SafeTide with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnsiliTech | 86% | |
| Jurata Thin Film | 81% | |
| Stablepharma | 78% | |
SafeTide Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 20, 2025 |
SafeTide Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders at the University of Cambridge | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2025
Received funding from Founders at the University of Cambridge.
SafeTide Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SafeTide's valuation, stock price, and market status.